Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Coagulation Factor Concentrates Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Coagulation Factor Concentrates Market Status and Forecast (2016-2027)
      • 1.3.2 Global Coagulation Factor Concentrates Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Coagulation Factor Concentrates Supply by Company

    • 2.1 Global Coagulation Factor Concentrates Sales Volume by Company
    • 2.2 Global Coagulation Factor Concentrates Sales Value by Company
    • 2.3 Global Coagulation Factor Concentrates Price by Company
    • 2.4 Coagulation Factor Concentrates Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Coagulation Factor Concentrates Market Status by Category

    • 3.1 Coagulation Factor Concentrates Category Introduction
      • 3.1.1 Factor VIII
      • 3.1.2 Factor IX
      • 3.1.3 Von Willebrand Factor
      • 3.1.4 Prothrombin Complex Concentrates
      • 3.1.5 Fibrinogen Concentrates
      • 3.1.6 Factor XIII
    • 3.2 Global Coagulation Factor Concentrates Market by Category
      • 3.2.1 Global Coagulation Factor Concentrates Sales Volume by Category (2016-2021)
      • 3.2.2 Global Coagulation Factor Concentrates Sales Value by Category (2016-2021)
      • 3.2.3 Global Coagulation Factor Concentrates Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Coagulation Factor Concentrates Market Status by End User/Segment

    • 4.1 Coagulation Factor Concentrates Segment by End User/Segment
      • 4.1.1 Neurology
      • 4.1.2 Immunology
      • 4.1.3 Hematology
      • 4.1.4 Critical Care
      • 4.1.5 Pulmonology
      • 4.1.6 Hemato-Oncology
      • 4.1.7 Rheumatology
      • 4.1.8 Others
    • 4.2 Global Coagulation Factor Concentrates Market by End User/Segment
      • 4.2.1 Global Coagulation Factor Concentrates Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Coagulation Factor Concentrates Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Coagulation Factor Concentrates Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Coagulation Factor Concentrates Market Status by Region

    • 5.1 Global Coagulation Factor Concentrates Market by Region
      • 5.1.1 Global Coagulation Factor Concentrates Sales Volume by Region
      • 5.1.2 Global Coagulation Factor Concentrates Sales Value by Region
    • 5.2 North America Coagulation Factor Concentrates Market Status
    • 5.3 Europe Coagulation Factor Concentrates Market Status
    • 5.4 Asia Pacific Coagulation Factor Concentrates Market Status
    • 5.5 Central & South America Coagulation Factor Concentrates Market Status
    • 5.6 Middle East & Africa Coagulation Factor Concentrates Market Status

    6 North America Coagulation Factor Concentrates Market Status

    • 6.1 North America Coagulation Factor Concentrates Market by Country
      • 6.1.1 North America Coagulation Factor Concentrates Sales Volume by Country (2016-2021)
      • 6.1.2 North America Coagulation Factor Concentrates Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Coagulation Factor Concentrates Market Status

    • 7.1 Europe Coagulation Factor Concentrates Market by Country
      • 7.1.1 Europe Coagulation Factor Concentrates Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Coagulation Factor Concentrates Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Coagulation Factor Concentrates Market Status

    • 8.1 Asia Pacific Coagulation Factor Concentrates Market by Country
      • 8.1.1 Asia Pacific Coagulation Factor Concentrates Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Coagulation Factor Concentrates Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Coagulation Factor Concentrates Market Status

    • 9.1 Central & South America Coagulation Factor Concentrates Market by Country
      • 9.1.1 Central & South America Coagulation Factor Concentrates Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Coagulation Factor Concentrates Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Coagulation Factor Concentrates Market Status

    • 10.1 Middle East & Africa Coagulation Factor Concentrates Market by Country
      • 10.1.1 Middle East & Africa Coagulation Factor Concentrates Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Coagulation Factor Concentrates Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Coagulation Factor Concentrates Manufacturing Cost Analysis
    • 11.5 Coagulation Factor Concentrates Sales Channel and Distributors Analysis
      • 11.5.1 Coagulation Factor Concentrates Sales Channel
      • 11.5.2 Coagulation Factor Concentrates Distributors
    • 11.6 Coagulation Factor Concentrates Downstream Major Buyers

    12 Global Coagulation Factor Concentrates Market Forecast by Category and by End User/Segment

    • 12.1 Global Coagulation Factor Concentrates Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Coagulation Factor Concentrates Forecast by Category
      • 12.2.1 Global Coagulation Factor Concentrates Sales Volume Forecast by Category
      • 12.2.2 Global Coagulation Factor Concentrates Sales Value Forecast by Category
      • 12.2.3 Global Coagulation Factor Concentrates Price Forecast by Category
    • 12.3 Global Coagulation Factor Concentrates Forecast by End User/Segment
      • 12.3.1 Global Coagulation Factor Concentrates Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Coagulation Factor Concentrates Sales Value Forecast by End User/Segment
      • 12.3.3 Global Coagulation Factor Concentrates Price Forecast by End User/Segment

    13 Global Coagulation Factor Concentrates Market Forecast by Region/Country

    • 13.1 Global Coagulation Factor Concentrates Market Forecast by Region (2022-2027)
      • 13.1.1 Global Coagulation Factor Concentrates Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Coagulation Factor Concentrates Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Shire (Ireland)
      • 14.1.1 Company Information
      • 14.1.2 Coagulation Factor Concentrates Product Introduction
      • 14.1.3 Shire (Ireland) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Shanghai RAAS Blood Products (China)
      • 14.2.1 Company Information
      • 14.2.2 Coagulation Factor Concentrates Product Introduction
      • 14.2.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanquin (Netherlands)
      • 14.3.1 Company Information
      • 14.3.2 Coagulation Factor Concentrates Product Introduction
      • 14.3.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Octapharma (Switzerland)
      • 14.4.1 Company Information
      • 14.4.2 Coagulation Factor Concentrates Product Introduction
      • 14.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 LFB (France)
      • 14.5.1 Company Information
      • 14.5.2 Coagulation Factor Concentrates Product Introduction
      • 14.5.3 LFB (France) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Kedrion (Italy)
      • 14.6.1 Company Information
      • 14.6.2 Coagulation Factor Concentrates Product Introduction
      • 14.6.3 Kedrion (Italy) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Japan Blood Products Organization, China Biologic Products (China)
      • 14.7.1 Company Information
      • 14.7.2 Coagulation Factor Concentrates Product Introduction
      • 14.7.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Grifols (Spain)
      • 14.8.1 Company Information
      • 14.8.2 Coagulation Factor Concentrates Product Introduction
      • 14.8.3 Grifols (Spain) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Green Cross Corporation (South Korea)
      • 14.9.1 Company Information
      • 14.9.2 Coagulation Factor Concentrates Product Introduction
      • 14.9.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 CSL (Australia)
      • 14.10.1 Company Information
      • 14.10.2 Coagulation Factor Concentrates Product Introduction
      • 14.10.3 CSL (Australia) Coagulation Factor Concentrates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Biotest (Germany)
    • 14.12 Bio Product Laboratory (UK)

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Coagulation Factor Concentrates market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Coagulation Factor Concentrates market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Factor VIII
      Factor IX
      Von Willebrand Factor
      Prothrombin Complex Concentrates
      Fibrinogen Concentrates
      Factor XIII

      Segmented by End User/Segment
      Neurology
      Immunology
      Hematology
      Critical Care
      Pulmonology
      Hemato-Oncology
      Rheumatology
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Shire (Ireland)
      Shanghai RAAS Blood Products (China)
      Sanquin (Netherlands)
      Octapharma (Switzerland)
      LFB (France)
      Kedrion (Italy)
      Japan Blood Products Organization, China Biologic Products (China)
      Grifols (Spain)
      Green Cross Corporation (South Korea)
      CSL (Australia)
      Biotest (Germany)
      Bio Product Laboratory (UK)
      Buy now